Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Cash | 0.090 | 1.900 | 1.810 |
Stocks | 99.840 | 99.840 | 0.000 |
Bonds | 0.070 | 0.070 | 0.000 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 15.987 | 15.176 |
Price to Book | 2.957 | 2.573 |
Price to Sales | 1.555 | 1.706 |
Price to Cash Flow | 9.094 | 9.600 |
Dividend Yield | 2.951 | 3.517 |
5 Years Earnings Growth | 8.528 | 8.580 |
Name | Net % | Category Average |
---|---|---|
Financial Services | 26.200 | 18.233 |
Industrials | 23.820 | 12.581 |
Consumer Defensive | 13.270 | 11.777 |
Technology | 9.240 | 14.793 |
Healthcare | 9.140 | 14.210 |
Consumer Cyclical | 5.840 | 8.453 |
Utilities | 5.810 | 5.475 |
Communication Services | 4.510 | 6.746 |
Basic Materials | 2.170 | 3.797 |
Number of long holdings: 170
Number of short holdings: 3
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Relx | GB00B2B0DG97 | 5.07 | 3,358.00 | +2.25% | |
Deutsche Boerse | DE0005810055 | 4.12 | 184.900 | +1.15% | |
Unilever | GB00B10RZP78 | 4.01 | 48.80 | -0.02% | |
Muench. Rueckvers. | DE0008430026 | 3.29 | 402.60 | -1.78% | |
Legrand | FR0010307819 | 3.23 | 95.34 | -2.40% | |
Omnicom | US6819191064 | 3.14 | 92.76 | +0.14% | |
Novartis | CH0012005267 | 3.12 | 87.97 | -1.01% | |
BlackRock | US09247X1019 | 3.11 | 763.48 | +0.86% | |
Colgate-Palmolive | US1941621039 | 3.02 | 92.88 | -0.03% | |
Sanofi | FR0000120578 | 3.02 | 91.30 | -0.65% |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Fidelity Funds Wrld Fund A Acc HKD | 13.53M | -7.09 | 12.87 | - | ||
Fidelity China Consumer A Acc HKD | 397.46M | -6.38 | -22.61 | -0.42 |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review